EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sacubitrilat exerts potent antiarrhythmic effects through activation of natriuretic peptide receptor-C

Manuel J Vogel, Luca F Gerres, Jonas Herting, Michael Kohlhaas iD, Lisa Krebes, Michaela Kuhn, Sabine Rebs, Katrin Streckfuss-Bömeke, Thomas Müller, Stefan Frantz iD, Christoph Maack iD, Thomas H Fischer

ESC Heart Failure · 2026

DOI: 10.1093/eschf/xvag253 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ESC Heart Failure, 2026. Verfasst von Manuel J Vogel und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, University Clinic Würzburg, Oberdürrbacherstraße 6, Würzburg D-97080, Germany. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Receptors, Atrial Natriuretic Factor, Arrhythmias, Cardiac. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Heart Research foundation, DFG, Interdisciplinary Center for Clinical Science at the University of Würzburg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Sacubitril, a neprilysin inhibitor used in the treatment of heart failure, has been shown to exert direct antiarrhythmic effects on ventricular cardiomyocytes. However, the underlying mechanisms and molecular targets remain to be elucidated. This study, therefore, aimed at investigating the direct antiarrhythmic properties of sacubitril and exploring a potential involvement of natriuretic peptides in the context of arrhythmia-induced cardiomyopathy (AIC). Methods and Results Diastolic sarcoplasmic reticulum (SR) Ca2+ leak was induced in isolated murine ventricular cardiomyocytes by enhancing late sodium current with ATX-II, and in human induced pluripotent stem cell-derived ventricular cardiomyocytes (iPSC-CM) by 24-h tachyarrhythmic stimulation. Diastolic Ca2+ leak and Ca2+ transient kinetics were quantified using confocal and epifluorescence microscopy, while pharmacological tools (CNP, ANP, NPR-C agonist cANP4-23, and NPR-C blocker osteocrin) dissected receptor involvement. In silico modelling explored potential binding sites of sacubitrilat to NPR-C. CNP, but not ANP, reversed the increases in Ca2+ spark frequency induced by ATX-II in murine ventricular cardiomyocytes. This effect was reproduced by selective NPR-C activation with cANP4-23 and abolished by NPR-C blockade with osteocrin. In a similar manner, sacubitrilat suppressed pathological SR Ca2+ leak in both murine and human iPSC-derived cardiomyocytes. This protection was fully lost when NPR-C was inhibited. Sacubitrilat did not cause any significant alterations in systolic Ca2+ release and SR Ca2+ load in murine ventricular cardiomyocytes. In silico modelling identified a plausible hydrophobic binding pocket for sacubitrilat at the NPR-C dimer, thus supporting a direct receptor interaction.

Conclusions

These data indicate that activation of NPR-C is both necessary and sufficient for the potent antiarrhythmic actions of sacubitrilat, mediating a selective reduction of arrhythmogenic SR Ca2+ leak in murine ventricular cardiomyocytes as well as in a cellular model of human AIC in iPSC-CM. NPR-C therefore emerges as a promising molecular target for the development of novel antiarrhythmic therapies suitable for patients with heart failure and arrhythmia-induced cardiomyopathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocytes, CardiacReceptors, Atrial Natriuretic FactorArrhythmias, CardiacAnimalsMiceHumansBiphenyl CompoundsDisease Models, AnimalCells, CulturedAnti-Arrhythmia AgentsHeart VentriclesMice, Inbred C57BL

Stichwörter der Autor:innen

EntrestoNPR-CNatriuretic peptidesSacubitrilVentricular arrhythmias

Substanzen

Receptors, Atrial Natriuretic FactorBiphenyl Compoundsatrial natriuretic factor receptor CAnti-Arrhythmia Agents

Autor:innen und Institutionen

  • Department of Internal Medicine I, University Clinic Würzburg, Oberdürrbacherstraße 6, Würzburg D-97080, Germany.
  • Comprehensive Heart Failure Center, University Clinic Würzburg, Am Schwarzenberg 15, Würzburg D-97078, Germany.
  • Institute of Physiology, University of Würzburg, Röntgenring 9, Würzburg D-97070, Germany.
  • Institute of Pharmacology and Toxicology, University of Würzburg, Versbacher Straße 9, Würzburg D-97078, Germany.
  • Medical Clinic I, Cardiology and Angiology, Justus-Liebig-University Gießen, Rudolf-Buchheim-Straße 8, Gießen D-35392, Germany.
  • Molecular Plant Physiology and Biophysics-Botanics I, University of Würzburg, Julius von Sachs Platz 2, Würzburg D-97072, Germany.

ORCID-Profile: Michael Kohlhaas, Stefan Frantz, Christoph Maack

Förderung

  • German Heart Research foundation
  • DFG
  • Interdisciplinary Center for Clinical Science at the University of Würzburg
  • COST Action

Zitieren

APA

Vogel, M. J., Gerres, L. F., Herting, J., Kohlhaas, M., Krebes, L., Kuhn, M., Rebs, S., Streckfuss-Bömeke, K., Müller, T., Frantz, S., Maack, C., & Fischer, T. H. (2026). Sacubitrilat exerts potent antiarrhythmic effects through activation of natriuretic peptide receptor-C. ESC Heart Failure. https://doi.org/10.1093/eschf/xvag253

Vancouver

Vogel MJ, Gerres LF, Herting J, Kohlhaas M, Krebes L, Kuhn M, et al. Sacubitrilat exerts potent antiarrhythmic effects through activation of natriuretic peptide receptor-C. ESC Heart Failure. 2026. doi:10.1093/eschf/xvag253

BibTeX
@article{Vogel2026,
  author = {Vogel, Manuel J and Gerres, Luca F and Herting, Jonas and Kohlhaas, Michael and Krebes, Lisa and Kuhn, Michaela and Rebs, Sabine and Streckfuss-Bömeke, Katrin and Müller, Thomas and Frantz, Stefan and Maack, Christoph and Fischer, Thomas H},
  title = {Sacubitrilat exerts potent antiarrhythmic effects through activation of natriuretic peptide receptor-C},
  journal = {ESC Heart Failure},
  year = {2026},
  doi = {10.1093/eschf/xvag253}
}
Kostenlos starten →